AnPac Bio Medical Science : Entry Into Definitive Investment Agreements - Form 6-K

Entry Into Definitive Investment Agreements

In December 2022 and January 2023, AnPac Bio-Medical Science Co., Ltd. (the "Company") signed definitive investment agreements with several third party investors, where the investors agreed to purchase 29,714,279 newly issued Class A ordinary shares (1,485,714 American Depositary Shares or "ADSs") of the Company at a price of US$0.175 per ordinary share or US$3.5 per ADS (1:20 ADS-to-share ratio), for a total purchase price of $5.2 million. Concurrently, for each Class A ordinary share purchased, the investors will receive from the Company two warrants with each warrant to purchase one Class A ordinary share at an exercise price of $0.21 per ordinary share (2,971,428 ADS an at exercise price of $4.20 per ADS). The warrants are exercisable within 2 years from the date of issuance. The closing is expected to take place within 30 days after signing.

This Report on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company.